The relationship between inflammatory markers and voxel-based gray matter volumes in nondemented older adults

Neurobiology of Aging

Volumn 37, Issue , 2016, Pages 138-146

  Zhang, Haobo ^a   Sachdev, Perminder S ^a,b   Wen, Wei ^a,b   Crawford, John D ^a   Brodaty, Henry ^a,b   Baune, Bernard T ^c   Kochan, Nicole A ^a,b   Slavin, Melissa J ^a   Reppermund, Simone ^a,d   Kang, Kristan ^a   Trollor, Julian N ^a,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Ageing; Correlation; Gray matter; Inflammatory markers; Magnetic resonance imaging; Voxel based morphometry

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; INTERLEUKIN 1BETA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; CYTOKINE;

AGED; AGING; ANTERIOR CINGULATE; APOE GENE; ARTICLE; BRAIN SIZE; CEREBELLUM; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DISEASE MARKER; FEMALE; FUSIFORM GYRUS; GENOTYPE; GRAY MATTER; HIPPOCAMPUS; HUMAN; INFERIOR PARIETAL LOBULE; INFLAMMATION; LEFT HEMISPHERE; MALE; MEDIAL PREFRONTAL CORTEX; NEUROANATOMY; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL GYRUS; SUPERIOR OCCIPITAL GYRUS; VERY ELDERLY; VOXEL BASED MORPHOMETRY; BRAIN; DIFFUSION WEIGHTED IMAGING; METABOLISM; ORGAN SIZE; PATHOLOGY;

AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; BRAIN; CYTOKINES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GRAY MATTER; HUMANS; INFLAMMATION MEDIATORS; MALE; ORGAN SIZE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84991408384     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.10.008     Document Type: Article

References (83)

1. Allison, A.C., Cacabelos, R., Lombardi, V.R., Alvarez, X.A., Vigo, C., Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 25 (2001), 1341–1357.
2. Alvarez, A., Cacabelos, R., Sanpedro, C., Garcia-Fantini, M., Aleixandre, M., Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol. Aging 28 (2007), 533–536.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, International Version (DSM-IV). 1995, American Psychiatric Association, Washington DC.
4. Anderson, T.M., Sachdev, P.S., Brodaty, H., Trollor, J.N., Andrews, G., Effects of sociodemographic and health variables on Mini-Mental State Exam scores in older Australians. Am. J. Geriatr. Psychiatry 15 (2007), 467–476.
5. Ashburner, J., A fast diffeomorphic image registration algorithm. Neuroimage 38 (2007), 95–113.
6. Banks, W.A., Farr, S.A., Morley, J.E., Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation 10 (2002), 319–327.
7. Baune, B.T., Konrad, C., Grotegerd, D., Suslow, T., Birosova, E., Ohrmann, P., Bauer, J., Arolt, V., Heindel, W., Domschke, K., Schoning, S., Rauch, A.V., Uhlmann, C., Kugel, H., Dannlowski, U., Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. J. Neuroinflammation, 9, 2012, 125.
8. Baune, B.T., Konrad, C., Grotegerd, D., Suslow, T., Ohrmann, P., Bauer, J., Arolt, V., Heindel, W., Domschke, K., Schoning, S., Rauch, A.V., Sehlmeyer, C., Kugel, H., Dannlowski, U., Tumor necrosis factor gene variation predicts Hippocampus volume in healthy individuals. Biol. Psychiatry 72 (2012), 655–662.
9. Baune, B.T., Ponath, G., Rothermundt, M., Roesler, A., Berger, K., Association between cytokines and cerebral MRI changes in the aging brain. J. Geriatr. Psychiatry Neurol. 22 (2009), 23–34.
10. Belarbi, K., Jopson, T., Tweedie, D., Arellano, C., Luo, W., Greig, N.H., Rosi, S., TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J. Neuroinflammation, 9, 2012, 23.
11. Bero, A.W., Yan, P., Roh, J.H., Cirrito, J.R., Stewart, F.R., Raichle, M.E., Lee, J.M., Holtzman, D.M., Neuronal activity regulates the regional vulnerability to amyloid-beta deposition. Nat. Neurosci. 14 (2011), 750–756.
12. Blann, A.D., McCollum, C.N., Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb. Haemost. 72 (1994), 151–154.
13. Breteler, M.M., van Swieten, J.C., Bots, M.L., Grobbee, D.E., Claus, J.J., van den Hout, J.H., van Harskamp, F., Tanghe, H.L., de Jong, P.T., van Gijn, J., Hofman, A., Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44 (1994), 1246–1252.
14. Brink, T.L., Geriatric depression and hypochondriasis: incidence, interaction, assessment and treatment. Psychother. Theor. Res. Pract. 19 (1982), 506–511.
15. Brondani, R., Rieder, C.R., Valente, D., Araujo, L.F., Clausell, N., Levels of vascular cell adhesion molecule-1 and endothelin-1 in ischemic stroke: a longitudinal prospective study. Clin. Biochem. 40 (2007), 282–284.
16. Bruunsgaard, H., The clinical impact of systemic low-level inflammation in elderly populations. With special reference to cardiovascular disease, dementia and mortality. Dan. Med. Bull. 53 (2006), 285–309.
17. Buckner, R.L., Snyder, A.Z., Shannon, B.J., LaRossa, G., Sachs, R., Fotenos, A.F., Sheline, Y.I., Klunk, W.E., Mathis, C.A., Morris, J.C., Mintun, M.A., Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25 (2005), 7709–7717.
18. Buckner, R.L., Vincent, J.L., Unrest at rest: default activity and spontaneous network correlations. Neuroimage 37 (2007), 1091–1096 discussion 7-9.
19. Carmeliet, P., Stassen, J.M., Schoonjans, L., Ream, B., van den Oord, J.J., De Mol, M., Mulligan, R.C., Collen, D., Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J. Clin. Invest. 92 (1993), 2756–2760.
20. D'Agostino, R.B. Sr., Vasan, R.S., Pencina, M.J., Wolf, P.A., Cobain, M., Massaro, J.M., Kannel, W.B., General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117 (2008), 743–753.
21. De Martinis, M., Franceschi, C., Monti, D., Ginaldi, L., Inflammation markers predicting frailty and mortality in the elderly. Exp. Mol. Pathol. 80 (2006), 219–227.
22. Drake, C., Boutin, H., Jones, M.S., Denes, A., McColl, B.W., Selvarajah, J.R., Hulme, S., Georgiou, R.F., Hinz, R., Gerhard, A., Vail, A., Prenant, C., Julyan, P., Maroy, R., Brown, G., Smigova, A., Herholz, K., Kassiou, M., Crossman, D., Francis, S., Proctor, S.D., Russell, J.C., Hopkins, S.J., Tyrrell, P.J., Rothwell, N.J., Allan, S.M., Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav. Immun. 25 (2011), 1113–1122.
23. Ewers, M., Mielke, M.M., Hampel, H., Blood-based biomarkers of microvascular pathology in Alzheimer's disease. Exp. Gerontol. 45 (2010), 75–79.
24. Eyre, H., Baune, B.T., Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 37 (2012), 1397–1416.
25. Fagiolo, U., Cossarizza, A., Scala, E., Fanales-Belasio, E., Ortolani, C., Cozzi, E., Monti, D., Franceschi, C., Paganelli, R., Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23 (1993), 2375–2378.
26. Fein, G., Di Sclafani, V., Tanabe, J., Cardenas, V., Weiner, M.W., Jagust, W.J., Reed, B.R., Norman, D., Schuff, N., Kusdra, L., Greenfield, T., Chui, H., Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 55 (2000), 1626–1635.
27. Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S., Bartali, B., Taub, D.D., Guralnik, J.M., Longo, D.L., The origins of age-related proinflammatory state. Blood 105 (2005), 2294–2299.
28. Folstein, M.F., Folstein, S.E., McHugh, P.R., “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975), 189–198.
29. Forlenza, O.V., Diniz, B.S., Talib, L.L., Mendonca, V.A., Ojopi, E.B., Gattaz, W.F., Teixeira, A.L., Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 28 (2009), 507–512.
30. Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., De Benedictis, G., Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908 (2000), 244–254.
31. Gabay, C., Kushner, I., Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340 (1999), 448–454.
32. Gallacher, J., Bayer, A., Lowe, G., Fish, M., Pickering, J., Pedro, S., Dunstan, F., White, J., Yarnell, J., Ben-Shlomo, Y., Is sticky blood bad for the brain?: Hemostatic and inflammatory systems and dementia in the Caerphilly Prospective Study. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 599–604.
33. Gao, H.M., Hong, J.S., Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 29 (2008), 357–365.
34. Grammas, P., Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J. Neuroinflammation, 8, 2011, 26.
35. Hayasaka, S., Phan, K.L., Liberzon, I., Worsley, K.J., Nichols, T.E., Nonstationary cluster-size inference with random field and permutation methods. Neuroimage 22 (2004), 676–687.
36. He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., Shen, Y., Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J. Cell Biol. 178 (2007), 829–841.
37. Iadecola, C., The pathobiology of vascular dementia. Neuron 80 (2013), 844–866.
38. Jefferson, A.L., Massaro, J.M., Wolf, P.A., Seshadri, S., Au, R., Vasan, R.S., Larson, M.G., Meigs, J.B., Keaney, J.F. Jr., Lipinska, I., Kathiresan, S., Benjamin, E.J., DeCarli, C., Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology 68 (2007), 1032–1038.
39. Kerrouche, N., Herholz, K., Mielke, R., Holthoff, V., Baron, J.C., 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis. J. Cereb. Blood Flow Metab. 26 (2006), 1213–1221.
40. Kim, Y., Kim, J.H., Nam, Y.J., Kim, Y.J., Yu, K.H., Lee, B.C., Lee, C., Sequence variants of ACE, AGT, AT1R, and PAI-1 as genetic risk factors for vascular dementia. Neurosci. Lett. 401 (2006), 276–279.
41. Koyama, A., O'Brien, J., Weuve, J., Blacker, D., Metti, A.L., Yaffe, K., The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J. Gerontol. A Biol. Sci. Med. Sci. 68 (2013), 433–440.
42. le Contel, C., Parant, F., Parant, M., Indirect and selective down-regulation of serum tumor necrosis factor-alpha release by interleukin-1 beta. Immunobiology 186 (1992), 199–213.
43. Leonard, B.E., Inflammation, depression and dementia: are they connected?. Neurochem. Res. 32 (2007), 1749–1756.
44. Liao, Y.F., Wang, B.J., Cheng, H.T., Kuo, L.H., Wolfe, M.S., Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J. Biol. Chem. 279 (2004), 49523–49532.
45. Lynch, J.R., Tang, W., Wang, H., Vitek, M.P., Bennett, E.R., Sullivan, P.M., Warner, D.S., Laskowitz, D.T., APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem. 278 (2003), 48529–48533.
46. Marsland, A.L., Gianaros, P.J., Abramowitch, S.M., Manuck, S.B., Hariri, A.R., Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol. Psychiatry 64 (2008), 484–490.
47. Marui, N., Offermann, M.K., Swerlick, R., Kunsch, C., Rosen, C.A., Ahmad, M., Alexander, R.W., Medford, R.M., Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92 (1993), 1866–1874.
48. McAfoose, J., Baune, B.T., Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 33 (2009), 355–366.
49. Mechelli, A., Price, C.J., Friston, K.J., Ashburner, J., Voxel-based morphometry of the human brain: methods and applications. Curr. Med. Imaging Rev. 1 (2005), 1–9.
50. Melchor, J.P., Pawlak, R., Strickland, S., The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J. Neurosci. 23 (2003), 8867–8871.
51. Metti, A.L., Cauley, J.A., How predictive of dementia are peripheral inflammatory markers in the elderly?. Neurodegener. Dis. Manag. 2 (2012), 609–622.
52. Mielke, R., Herholz, K., Grond, M., Kessler, J., Heiss, W.D., Severity of vascular dementia is related to volume of metabolically impaired tissue. Arch. Neurol. 49 (1992), 909–913.
53. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001), 683–765.
54. Nagata, K., Maruya, H., Yuya, H., Terashi, H., Mito, Y., Kato, H., Sato, M., Satoh, Y., Watahiki, Y., Hirata, Y., Yokoyama, E., Hatazawa, J., Can PET data differentiate Alzheimer's disease from vascular dementia?. Ann. N. Y. Acad. Sci. 903 (2000), 252–261.
55. Nichols, T., Brett, M., Andersson, J., Wager, T., Poline, J.B., Valid conjunction inference with the minimum statistic. Neuroimage 25 (2005), 653–660.
56. O'Bryant, S.E., Johnson, L., Edwards, M., Soares, H., Devous, M.D., Ross, S., Rohlfing, G., Hall, J., The link between C-reactive protein and Alzheimer's disease among Mexican Americans. J. Alzheimers Dis. 34 (2013), 701–706.
57. Pantel, J., Schroder, J., Essig, M., Jauss, M., Schneider, G., Eysenbach, K., von Kummer, R., Baudendistel, K., Schad, L.R., Knopp, M.V., In vivo quantification of brain volumes in subcortical vascular dementia and Alzheimer's disease. An MRI-based study. Dement. Geriatr. Cogn. Disord. 9 (1998), 309–316.
58. Perry, V.H., Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol. 120 (2010), 277–286.
59. Raichle, M.E., MacLeod, A.M., Snyder, A.Z., Powers, W.J., Gusnard, D.A., Shulman, G.L., A default mode of brain function. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 676–682.
60. Raz, N., Lindenberger, U., Rodrigue, K.M., Kennedy, K.M., Head, D., Williamson, A., Dahle, C., Gerstorf, D., Acker, J.D., Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb. Cortex 15 (2005), 1676–1689.
61. Reale, M., Greig, N.H., Kamal, M.A., Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases. Mini Rev. Med. Chem. 9 (2009), 1229–1241.
62. Rosano, C., Marsland, A.L., Gianaros, P.J., Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging. Aging Dis. 3 (2012), 16–33.
63. Sachdev, P.S., Brodaty, H., Reppermund, S., Kochan, N.A., Trollor, J.N., Draper, B., Slavin, M.J., Crawford, J., Kang, K., Broe, G.A., Mather, K.A., Lux, O., The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int. Psychogeriatr. 22 (2010), 1248–1264.
64. Sastre, M., Walter, J., Gentleman, S.M., Interactions between APP secretases and inflammatory mediators. J. Neuroinflammation, 5, 2008, 25.
65. Satizabal, C.L., Zhu, Y.C., Mazoyer, B., Dufouil, C., Tzourio, C., Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study. Neurology 78 (2012), 720–727.
66. Seo, S.W., Ahn, J., Yoon, U., Im, K., Lee, J.M., Tae Kim, S., Ahn, H.J., Chin, J., Jeong, Y., Na, D.L., Cortical thinning in vascular mild cognitive impairment and vascular dementia of subcortical type. J. Neuroimaging 20 (2010), 37–45.
67. Sheikh, J.I., Yesavage, J.A., Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. TL, B., (eds.) Clinical Gerontology: A Guide to Assessment and Intervention, 1986, The Hawthorn Press, New York, 165–173.
68. Singh, T., Newman, A.B., Inflammatory markers in population studies of aging. Ageing Res. Rev. 10 (2011), 319–329.
69. Stowe, R.P., Peek, M.K., Cutchin, M.P., Goodwin, J.S., Plasma cytokine levels in a population-based study: relation to age and ethnicity. J. Gerontol. A Biol. Sci. Med. Sci. 65 (2010), 429–433.
70. Swardfager, W., Lanctot, K., Rothenburg, L., Wong, A., Cappell, J., Herrmann, N., A meta-analysis of cytokines in Alzheimer's disease. Biol. Psychiatry 68 (2010), 930–941.
71. Tan, Z.S., Beiser, A.S., Vasan, R.S., Roubenoff, R., Dinarello, C.A., Harris, T.B., Benjamin, E.J., Au, R., Kiel, D.P., Wolf, P.A., Seshadri, S., Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 68 (2007), 1902–1908.
72. Tjarnlund-Wolf, A., Brogren, H., Lo, E.H., Wang, X., Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases. Stroke 43 (2012), 2833–2839.
73. Trollor, J.N., Smith, E., Baune, B.T., Kochan, N.A., Campbell, L., Samaras, K., Crawford, J., Brodaty, H., Sachdev, P., Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement. Geriatr. Cogn. Disord. 30 (2010), 569–578.
74. Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., Joliot, M., Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15 (2002), 273–289.
75. Urieli-Shoval, S., Linke, R.P., Matzner, Y., Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7 (2000), 64–69.
76. Wang, T., Xiao, S., Liu, Y., Lin, Z., Su, N., Li, X., Li, G., Zhang, M., Fang, Y., The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease. Int. J. Geriatr. Psychiatry 29 (2014), 713–719.
77. Wishart, H.A., Saykin, A.J., McAllister, T.W., Rabin, L.A., McDonald, B.C., Flashman, L.A., Roth, R.M., Mamourian, A.C., Tsongalis, G.J., Rhodes, C.H., Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 67 (2006), 1221–1224.
78. Worsley, K.J., Andermann, M., Koulis, T., MacDonald, D., Evans, A.C., Detecting changes in nonisotropic images. Hum. Brain Mapp. 8 (1999), 98–101.
79. Wyss-Coray, T., Rogers, J., Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb. Perspect. Med., 2, 2012, a006346.
80. Yoon, C.W., Seo, S.W., Park, J.S., Kwak, K.C., Yoon, U., Suh, M.K., Kim, G.H., Shin, J.S., Kim, C.H., Noh, Y., Cho, H., Kim, M.J., Kim, J.H., Roh, J.H., Lee, J.M., Na, D.L., Cerebellar atrophy in patients with subcortical-type vascular cognitive impairment. Cerebellum 12 (2013), 35–42.
81. Zhang, H., Sachdev, P.S., Wen, W., Kochan, N.A., Crawford, J.D., Brodaty, H., Slavin, M.J., Reppermund, S., Draper, B., Zhu, W., Kang, K., Trollor, J.N., Gray matter atrophy patterns of mild cognitive impairment subtypes. J. Neurol. Sci. 315 (2012), 26–32.
82. Zhang, H., Sachdev, P.S., Wen, W., Kochan, N.A., Zhu, W., Crawford, J.D., Brodaty, H., Slavin, M.J., Reppermund, S., Kang, K., Trollor, J.N., Neuroanatomical correlates of cognitive performance in late life. Dement. Geriatr. Cogn. Disord. 32 (2011), 216–226.
83. Zuliani, G., Cavalieri, M., Galvani, M., Passaro, A., Munari, M.R., Bosi, C., Zurlo, A., Fellin, R., Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J. Neurol. Sci. 272 (2008), 164–170.